586 related articles for article (PubMed ID: 27188458)
1. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
[TBL] [Abstract][Full Text] [Related]
2. SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma.
Cui XB; Shen YY; Jin TT; Li S; Li TT; Zhang SM; Peng H; Liu CX; Li SG; Yang L; Li N; Hu JM; Jiang JF; Li M; Liang WH; Li Y; Wei YT; Sun ZZ; Wu CY; Chen YZ; Li F
J Transl Med; 2015 Oct; 13():321. PubMed ID: 26444413
[TBL] [Abstract][Full Text] [Related]
3. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
4. Expression and Significance of TRIM 28 in Squamous Carcinoma of Esophagus.
Liu B; Li X; Liu F; Li F; Wei S; Liu J; Lv Y
Pathol Oncol Res; 2019 Oct; 25(4):1645-1652. PubMed ID: 30484263
[TBL] [Abstract][Full Text] [Related]
5. RANK overexpression as a novel esophageal cancer marker: validated immunohistochemical analysis of two different ethnicities.
Cui X; Peng H; Jin J; Li T; Zhang S; Jin T; Li S; Liu C; Liang W; Li F; Chen Y
Int J Clin Exp Pathol; 2015; 8(2):2249-58. PubMed ID: 25973136
[TBL] [Abstract][Full Text] [Related]
6. PIK3CA promotes proliferation and motility but is unassociated with lymph node metastasis or prognosis in esophageal squamous cell carcinoma.
Zheng S; Yang C; Lu M; Liu Q; Liu T; Dai F; Gao X; Sheyhidin I; Lu X
Hum Pathol; 2016 Jul; 53():121-9. PubMed ID: 27001433
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of 14-3-3σ correlates with multistage carcinogenesis and poor prognosis of esophageal squamous cell carcinoma.
Qi YJ; Wang M; Liu RM; Wei H; Chao WX; Zhang T; Lou Q; Li XM; Ma J; Zhu H; Yang ZH; Liu HQ; Ma YF
PLoS One; 2014; 9(4):e95386. PubMed ID: 24743601
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of zinc finger E-box binding homeobox factor 1 promotes tumor invasiveness and confers unfavorable prognosis in esophageal squamous cell carcinoma.
Yang X; Wang Q; Dai W; Zhang J; Chen X
Tumour Biol; 2014 Dec; 35(12):11977-84. PubMed ID: 25142232
[TBL] [Abstract][Full Text] [Related]
9. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
10. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
[TBL] [Abstract][Full Text] [Related]
11. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.
Yokobori T; Suzuki S; Tanaka N; Inose T; Sohda M; Sano A; Sakai M; Nakajima M; Miyazaki T; Kato H; Kuwano H
Cancer Sci; 2013 Jan; 104(1):48-54. PubMed ID: 23013135
[TBL] [Abstract][Full Text] [Related]
12. USP9X expression correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Peng J; Hu Q; Liu W; He X; Cui L; Chen X; Yang M; Liu H; Wei W; Liu S; Wang H
Diagn Pathol; 2013 Oct; 8():177. PubMed ID: 24152793
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro.
Yang Z; Wu Z; Liu T; Han L; Wang C; Yang B; Zheng F
Med Oncol; 2014 Dec; 31(12):337. PubMed ID: 25416048
[TBL] [Abstract][Full Text] [Related]
14. Connective tissue growth factor expression in precancerous lesions of human esophageal epithelium and prognostic significance in esophageal squamous cell carcinoma.
Li LY; Li EM; Wu ZY; Huang X; Shen JH; Xu XE; Wu JY; Huang Q; Xu LY
Dis Esophagus; 2011 Jul; 24(5):337-45. PubMed ID: 21143696
[TBL] [Abstract][Full Text] [Related]
15. LncRNA CASC9 promotes tumorigenesis by affecting EMT and predicts poor prognosis in esophageal squamous cell cancer.
Gao GD; Liu XY; Lin Y; Liu HF; Zhang GJ
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):422-429. PubMed ID: 29424900
[TBL] [Abstract][Full Text] [Related]
16. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P
Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162
[TBL] [Abstract][Full Text] [Related]
17. Myosin 5a regulates tumor migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma: utility as a prognostic factor.
Sato N; Fujishima F; Nakamura Y; Aoyama Y; Onodera Y; Ozawa Y; Ito K; Ishida H; Kamei T; Watanabe M; Sasano H
Hum Pathol; 2018 Oct; 80():113-122. PubMed ID: 29898384
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
19. TESC acts as a prognostic factor and promotes epithelial-mesenchymal transition progression in esophageal squamous carcinoma.
Dong Y; Fan B; Li M; Zhang J; Xie S; Di S; Jia Q; Gong T
Pathol Res Pract; 2024 Jan; 253():154964. PubMed ID: 38000203
[TBL] [Abstract][Full Text] [Related]
20. Podoplanin is expressed at the invasive front of esophageal squamous cell carcinomas and is involved in collective cell invasion.
Nakashima Y; Yoshinaga K; Kitao H; Ando K; Kimura Y; Saeki H; Oki E; Morita M; Kakeji Y; Hirahashi M; Oda Y; Maehara Y
Cancer Sci; 2013 Dec; 104(12):1718-25. PubMed ID: 24103048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]